Physician profile
Stuart Jacobson
NPI 1841327210
$13,360.14
in general payments reported to CMS, 2019-2025
35 companies · $196 in 2025
The $196 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,994 · 2020: $771 · 2021: $993 · 2022: $1,233 · 2023: $741 · 2024: $432 · 2025: $196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,039 · Consulting Fee: $330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,039.33 |
| Consulting Fee | $330.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $5,892.45 | 2019-2020 | |
| Boston Scientific Corporation | $1,719.37 | 2019-2025 | Rotapro, Avvigo Guidance System, Rotablator Rotational Atherectomy System Console Kit |
| Abbott Laboratories | $870.51 | 2019-2024 | Optis |
| Abiomed | $840.50 | 2019-2022 | |
| Amgen INC. | $573.90 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $428.72 | 2019-2024 | |
| Biosense Webster, INC. | $330.00 | 2023 | Smartablatetm System Rf Generator |
| Janssen Pharmaceuticals, INC | $278.05 | 2019 | |
| Medtronic, INC. | $260.52 | 2021-2022 | |
| Pfizer INC. | $257.07 | 2019-2023 | |
| Amarin Pharma, INC. | $230.50 | 2019-2020 | |
| Inari Medical, INC. | $207.69 | 2021-2022 | |
| Shockwave Medical, INC | $160.80 | 2022 | |
| Esperion Therapeutics, INC. | $146.84 | 2020-2022 | |
| Heartflow, INC. | $129.26 | 2020-2023 | Ffrct |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $124.61 | 2023-2024 | Glidesheath Slender, Tr Band |
| Sanofi-Aventis U.S. LLC | $105.12 | 2019-2020 | |
| Novo Nordisk INC | $100.12 | 2019 | |
| Philips North America LLC | $87.58 | 2020-2023 | |
| Astellas Pharma US INC | $73.72 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $63.48 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $61.30 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $58.86 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $57.77 | 2019-2021 | |
| Biotronik INC. | $54.95 | 2024 | Acticor 7 Vr-T Dx |
| Chiesi USA, INC. | $46.01 | 2019 | |
| Cardiovascular Systems INC. | $37.11 | 2020-2021 | |
| Impulse Dynamics (USA) INC. | $26.61 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $26.44 | 2019-2022 | |
| Irhythm Technologies, INC. | $25.57 | 2020 | |
| Edwards Lifesciences Corporation | $23.48 | 2019 | |
| Lundbeck LLC | $22.45 | 2019 | |
| Merck Sharp & Dohme LLC | $13.39 | 2022 | |
| Cvrx, INC. | $12.74 | 2021 | |
| Tactile Systems Technology INC | $12.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Jacobson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.